 |

| August 11, 2008 Issue |
Volume 70, Number 32 |
Lead Stories for this Issue
Covance R&D Deal Meshes With Lilly’s “FIPNet” ModelAdvisory Committee Policy Allows Members With Financial Conflicts To VoteMedco Personalized Medicine Research Shows “Real World” Promise – Frueh
Go to this Issue >>
|
| August 4, 2008 Issue |
Volume 70, Number 31 |
Lead Stories for this Issue
FDA Draws Upon New Authority To Mandate Elements OF ESA LabelingRoche’s Actemra Postmarket Safety Plan May Obviate Need For REMSAcademic Detailing Bill Could Be Interim Step To Comparative Effectiveness
Go to this Issue >>
|
| July 28, 2008 Issue |
Volume 70, Number 30 |
Lead Stories for this Issue
Roche’s High Stakes Gambit For Genentech Pipeline Dreams: GSK’s Witty Outlines Plans To Lower Phase III Attrition Republican Strategy To Protect Part D Raises Risks For Pharma
Go to this Issue >>
|
|
 |
|
 |